PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 1, 2025Biostatistics1 citationsOpen Access

A Bayesian semi-parametric approach to causal mediation for longitudinal mediators and time-to-event outcomes with application to a cardiovascular disease cohort study

View Full Paper
SBSubir Kumar BhandariMDMichael J. DanielsMJMaria Josefsson

Key Points

  • Causal mediation analysis indicates that medications can significantly delay time-to-CVD death in observational studies.
  • Using data from the Atherosclerosis Risk in Communities cohort, the study assesses direct and indirect causal effects on disease progression.
  • The Bayesian semi-parametric approach addresses complexities like longitudinal mediators and time-varying confounders in causal analysis.
  • Findings underscore the importance of robust causal mediation methods to inform treatment of cardiovascular risk factors in clinical settings.

Abstract

Summary Causal mediation analysis of observational data is an important tool for investigating the potential causal effects of medications on disease-related risk factors, and on time-to-death (or disease progression) through these risk factors. However, when analyzing data from a cohort study, such analyses are complicated by the longitudinal structure of the risk factors and the presence of time-varying confounders. Leveraging data from the Atherosclerosis Risk in Communities (ARIC) cohort study, we develop a causal mediation approach, using (semi-parametric) Bayesian Additive Regression Tree (BART) models for the longitudinal and survival data. Our framework is developed using static longitudinal exposure regimes and allows for time-varying confounders and mediators, both of which can be either continuous or binary. We also identify and estimate direct and indirect causal effects in the presence of a competing event. We apply our methods to assess how medication, prescribed to target cardiovascular disease (CVD) risk factors, affects the time-to-CVD death.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bhandari et al. (2024) studied this question.

synapsesocial.com/papers/68dd953bfe798ba2fc499aa4https://doi.org/10.1093/biostatistics/kxaf027
Ask AI
Helpful
Bookmark
Share
View Full Paper